Clinical trial
Analgesic Effectiveness of Three Different Doses of a New Formulation of…
NCT00264225 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00264225 |
|---|---|
| Title | Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis) |
| Official title | A Randomized, Double-Blind, Comparative Parallel Group Study of Analgesic Effectiveness and Safety of Three Different Doses of Lamaline® New Formulation vs Dafalgan® Codeine, After 10 Days Administration in Subjects With Painful Gonarthrosis. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Knee Osteoarthritis |
| Intervention type | Drug |
| Interventions | Lamaline®, 3 different doses, Dafalgan codeine |
| Start date | Dec 1, 2005 |
| First posted | Dec 12, 2005 |
| Last update posted | Feb 20, 2008 |
| Countries | France |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: